University of Minnesota Medical Center

Minneapolis, Minnesota 55455-0341

17 studies enrolling now · 131 studies all time

What they study most

ADA SCID, ADA-SCID, AIDS, AIDS and Infections, AML, Acute Graft-versus-host Disease, Acute Respiratory Failure, Adult Hematopoietic Cell Transplant (HCT) Survivors 1-2 Yrs Post Most Recent HCT, Advanced Melanoma, Aids/Hiv Problem, Angioplasty, Anxiety

Studies at this site

• A Study to Assess the Efficacy and Safety of Emicizumab in Participants With Type 3 Von Willebrand Disease — Recruiting now
• A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer — Recruiting now
• A Study of Pasritamig Versus Placebo in Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC) — Recruiting now
• A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma — Recruiting now
• Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL — Recruiting now
• VE303 for Prevention of Recurrent Clostridioides Difficile Infection — Recruiting now
• Study to Evaluate the Safety and Efficacy of Larsucosterol in Participants With Alcohol-associated Hepatitis (AH) — Recruiting now
• Durability of Suppl. Rod Constructs-SuppleMentAry Rod Technique for Long-segment Posterior Instrumented Spinal Fusions — Recruiting now
• Preoperative Fasting vs. Not Fasting in Critically Ill Patients — Recruiting now
• Ketamine add-on Therapy for Established Status Epilepticus Treatment Trial (KESETT) — Recruiting now
• Outcomes and Health Care Resource Utilization in Pediatric Congenital Heart Disease Patients Undergoing Non-Cardiac Procedures — Recruiting now
• Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM) — Recruiting now
• Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01) — Recruiting now
• Evaluation of Accuracy of the Owlet OSS 3.0 Sensor in the Neonatal Population — Recruiting now
• Staged Complete Revascularization for Coronary Artery Disease vs Medical Management Alone in Patients With AS Undergoing Transcatheter Aortic Valve Replacement — Recruiting now
• PARTNER 3 Trial - Aortic Valve-in-Valve — Recruiting now
• Safety and Efficacy of Tegoprubart in Patients Undergoing Kidney Transplantation — Completed
• A Phase 1b/2 Trial of the Safety and Microbiological Activity of Bacteriophage Therapy in Cystic Fibrosis Subjects Colonized With Pseudomonas Aeruginosa — Completed
• An Observational Study of Participants With Type 3 Von Willebrand Disease on Prophylactic Standard-of-Care Treatment — Running, not enrolling
• Global Patient Registry of Inherited Retinal Diseases — Running, not enrolling
• Open-Label Rollover Study of Levosimendan in PH-HFpEF Patients — Completed
• Dose-Ranging Study of ST-920, an AAV2/6 Human Alpha Galactosidase A Gene Therapy in Subjects With Fabry Disease (STAAR) — Completed
• Artificial Urinary Sphincter Clinical Outcomes — Completed
• PARTNER 3 Trial: Safety and Effectiveness of the SAPIEN 3 Transcatheter Heart Valve in Low Risk Patients With Aortic Stenosis — Running, not enrolling
• A Phase 3, Randomized, Double-blind Study for Patients With Invasive Candidiasis Treated With IV Echinocandin Followed by Either Oral Ibrexafungerp or Oral Fluconazole — Stopped early
• Post Approval Study of the BARD® COVERA™ Arteriovenous (AV) Stent Graft — Completed
• Long-Term Safety and Efficacy of Tegoprubart in Kidney Transplant Recipients — Enrolling by invitation
• Safety and Efficacy of Itacitinib in Combination With Corticosteroids for Treatment of Graft-Versus-Host Disease in Pediatric Subjects — Stopped early
• Novel DBS Device in Parkinson's Disease — Completed
• A Phase 1/2 Study to Evaluate Axatilimab in Participants With Active cGVHD — Completed
• STRIDE Study - A Study in Subjects With LOPD Who Are Currently Being Treated With ERT — Stopped early
• Long-Term Follow-up of Subjects Who Were Treated With ST-920 — Enrolling by invitation
• Applications of MRI in Kidney Disease — Withdrawn before enrolling
• The Efficacy and Safety of SerpinPC in Participants with Severe Hemophilia a or Moderately Severe to Severe Hemophilia B — Stopped early
• International EXPAND Heart Pivotal Trial — Completed
• Hemodynamic Evaluation of Levosimendan in Patients With PH-HFpEF — Completed
• SGI-110 in Adults With Untreated Acute Myeloid Leukemia (AML), Not Considered Candidates for Intensive Remission Induction — Completed
• To Evaluate the Safety of Long-term Use of HPN-100 in the Management of Urea Cycle Disorders (UCDs) — Completed
• Dose Escalation and Efficacy Study of mRNA-2416 for Intratumoral Injection Alone and in Combination With Durvalumab for Participants With Advanced Malignancies — Stopped early
• Study of the Safety of HPN (Hyperion)-100 for the Long-Term Treatment of Urea Cycle Disorders (Treat UCD) — Completed
• Efficacy and Safety of HPN-100 for the Treatment of Adults With Urea Cycle Disorders — Completed
• A Study to Evaluate Long Term Safety and Efficacy of Recombinant Human Pentraxin-2 (rhPTX-2; PRM-151) in Participants With Idiopathic Pulmonary Fibrosis — Stopped early
• EARLY TAVR: Evaluation of TAVR Compared to Surveillance for Patients With Asymptomatic Severe Aortic Stenosis — Running, not enrolling
• A Study to Evaluate the Efficacy and Safety of Recombinant Human Pentraxin-2 (rhPTX-2; PRM-151) in Participants With Idiopathic Pulmonary Fibrosis — Stopped early
• Circuit-Based Deep Brain Stimulation for Parkinson's Disease; Udall Project 1 Aim 2 and 3 — Completed
• Valiant Evo US Clinical Trial — Completed
• A Study Of Avelumab In Patients With Locally Advanced Or Metastatic Urothelial Cancer (JAVELIN Bladder 100) — Completed
• Observational Study of Solid Organ Transplantation Utilizing HIV-Positive Donors in HIV-Positive Recipients — Completed
• A Registry for Participants With Cirrhosis Who Achieve a Sustained Virologic Response Following Treatment With a Sofosbuvir-Based Regimen Without Interferon for Chronic Hepatitis C Infection — Stopped early
• BioVentrix Revivent TC™ System Clinical Study — Running, not enrolling